Exploration of the underlying molecular mechanisms demonstrated that intracellular S100A7 binds to JAB1 to promote the activation of the cancer‐associated AKT, ERK, and NF‐kB signaling pathways, thereby promoting ESCC progression. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.